Cost-Containment

FDA moves to stabilize drug supply and costs via new manufacturing initiative

The goal of the program, according to the agency, is to increase regulatory predictability, facilitate the construction of manufacturing sites in the United States and streamline aspects of pharmaceutical manufacturing facility assessments in advance of a specific product application.